Description
First immunoassay for persistent forms of Borrelia burgdorferi
TickPlex Plus allows for simultaneous determination of IgM and IgG antibodies for multiple bacterial and viral pathogens. With its high sensitivity of approximately 95% and specificity of approximately 98%, it outperforms comparable IFT testing methods to date.
Testing with TickPlex Plus detects antibodies against the pathogens -:
Borrelia burgdorferi (including persistent forms / round bodies)
Ehrlichia chaffeensis
Mycoplasma pneumonia & fermentans
Bartonella henselae
Rickettsia akari
Babesia microti
Epstein-Barr Virus (EBV)
Human Parvovirus B19
Coxsackievirus type A16
– using the more sensitive and specific ELISA compared to all previously available IFT testing methods. The results of the TickPlex must always be evaluated by the therapist in conjunction with the patient’s clinical symptoms and differential diagnoses. The TickPlex can be used in various stages of disease.
Information about the certification of the TickPlex:
Tezted ISO 13485 Certificate
Tickplex Validation Process
EU declaration of conformity for Tickplex Plus